It has become one of the defining stories in Healthcare Technology — and it is reshaping how the sector operates across Europe. Sweekly spoke with executives, engineers and investors to understand what is really driving the shift, and what it means for the businesses that will live with the consequences.
In the clinic, the system reads scans alongside radiologists, flagging what the eye might miss.
The clinical case
The data infrastructure behind precision medicine is as important as any single device.
The regulatory path under the new EU framework is longer, and companies have adjusted their timelines accordingly.
“The algorithm doesn't replace the radiologist. It makes sure the radiologist never misses the obvious.”— Chief Medical Officer
The evidence
Reimbursement, not technology, is the gate most digital-health products fail to clear.
Clinicians are cautious adopters, and rightly so — trust is earned slowly here.
What to watch
- Interoperability with existing hospital systems
- Reimbursement pathways that make adoption viable
- Evidence from independent, multi-site clinical trials
- A clear regulatory path under the new EU rules
The technology
Point-of-care diagnostics compress days of waiting into minutes.
Evidence from multi-site trials is finally catching up to the marketing claims.
The bottom line
In the clinic, the system reads scans alongside radiologists, flagging what the eye might miss.
Sources & further reading
Written by
Nora SundqvistHealthcare Tech Correspondent
Nora reports on the devices and platforms changing how care is delivered.
Discussion(3)
We're seeing exactly this on the ground. The economics only work once the software ties it together.
I'm a bit more skeptical on the timeline, but the direction of travel is undeniable.
Great reporting as always from the Sweekly desk. The data on adoption is eye-opening.